ADD-What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow? - 101867

Spotlight
Video

ADD-What impact do Revlimid® (lenalidomide) and Pomalyst® (pomalidomide) have on the bone marrow?

Loading........
Description: In this week’s video, Brian G.M. Durie explains that even though Revlimid and Pomalyst may reduce white blood cell counts, they do not permanently affect the bone marrow.

BOTTOM LINE:
Revlimid and Pomalyst may reduce white blood cell counts, so stop or adjust dosing accordingly.
Shared By : InternationalMyelomaFoundation
Posted on : 03/26/18
Added : 1 year ago
Category : Multiple Myeloma